Clinical trial

Tocotrienol as a Nutritional Supplement in Patients With Advanced Lung Cancer

NCT02644252

StatusTERMINATED

Study typeINTERVENTIONAL

Start date2016-01-01

PhasePHASE3

Study timeline

Study start (actual)2016-01-01Date precision: month

Registry last updated2021-05-03

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Lung Cancerunresolved

Interventions

Day 1: Cisplatin 75 mg/m2DRUG

Day 1: Vinorelbine 25 mg/m2DRUG

Day 8: Capsule vinorelbine 50 mg/m2DRUG

Day 1: Carboplatin AUC=5DRUG

Day 1: Vinorelbine 30 mg/m2DRUG

Day 8: Capsule vinorelbine 60 mg/m2DRUG

Tocotrienol 300 mg x 3 daily until progressionDIETARY_SUPPLEMENT

Placebo 1 capsule x 3 daily until progressionDRUG

Sponsors & collaborators

Vejle Hospitallead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02644252 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.